Company Momenta Pharmaceuticals, Inc.
Equities
MNTA
US60877T1007
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Lee
PSD | President | - | - |
Patty Eisenhaur
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 19-03-31 | |
Ian D. Fier
PRN | Corporate Officer/Principal | - | 02-09-30 |
Human Resources Officer | - | 07-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20-09-30 | |
Director/Board Member | - | 20-09-30 | |
Jonathan Bryant
BRD | Director/Board Member | - | 20-09-30 |
David Lee
PSD | President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 119,533,224 | 118,124,353 ( 98.82 %) | 568,000 ( 0.4752 %) | 98.82 % |
Company contact information
Momenta Pharmaceuticals, Inc.
1125 Trenton-harbourton Road
08560, Titusville
+617 491 9700
http://www.momentapharma.comSector
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |